improved infection efficiency using the Ad5/35E1aPSESE4 adenovirus in conjunction with PSA/PSMA transcription regulatory elements, but this approach is largely restricted to prostate cancer applications (51). This evidence concerns the gene FOLH1 and prostate carcinoma.